Literature DB >> 2213570

Evidence that the P2x purinoceptor of the smooth muscle of the guinea pig vas deferens is an ATP4- receptor.

J S Fedan1, J P Dagirmanjian, M D Attfield, E W Chideckel.   

Abstract

In solutions containing Mg2+ and Ca2+, ATP is in equilibrium between the tetrabasic form (ATP4-) and its bidentate coordination complexes, i.e., MgATP2- and CaATP2-. We sought evidence to determine whether contractions of the smooth muscle of the guinea pig vas deferens to ATP are in response to ATP4- or its bidentate complexes. Contractions to ATP were elicited in seven modified Krebs-Henseleit solutions containing varied concentrations of free and total Mg2+ and Ca2+ to alter the concentration of ATP4- at given ATPtotal concentrations. As the concentration of Mg2+ increased the concentration of ATP required to stimulate contraction to an equivalent degree also increased. Regardless of the free or total Mg2+ and Ca2+ concentrations, response magnitude was generally correlated with [ATP4-]. This suggests that ATP4- is the agonist at the P2x purinoceptor of the guinea pig vas deferens. The potency of ATP4- is high; the threshold, occurring at approximately 1 nM ATP4-, is 1000-fold less than that for norepinephrine. The implications of ATP4- as agonist are discussed in relation to adenine nucleotide potency, metabolism and P2 purinoceptor classification.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213570

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

2.  Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  Evidence that a form of ATP uncomplexed with divalent cations is the ligand of P2y and nucleotide/P2u receptors on aortic endothelial cells.

Authors:  S Motte; S Pirotton; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.

Authors:  A D Michel; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

5.  Effects of metal cations on [3H]alpha,beta-methylene ATP binding in rat vas deferens.

Authors:  A D Michel; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

6.  Contribution of P2-purinoceptors to neurogenic contraction of rat urinary bladder smooth muscle.

Authors:  M Hashimoto; S Kokubun
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  Characterization of Na+ influx mediated by ATP(4-)-activated P2 purinoceptors in PC12 cells.

Authors:  S Y Choi; K T Kim
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

8.  Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries.

Authors:  V Ralevic; C H Hoyle; G Burnstock
Journal:  J Physiol       Date:  1995-03-15       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.